Qatar Genome Programme

The Qatar Genome Programme, housed under Qatar Foundation, is sequencing the genomes of Qatar's diverse population to build a comprehensive genetic reference database for Arab and Middle Eastern populations. These populations are significantly underrepresented in global genomic databases, which are predominantly based on European-ancestry individuals, leading to disparities in precision medicine applications.

The programme enables pharmacogenomics research tailored to regional populations — identifying which drugs work best for specific genetic profiles common in Arab populations, optimizing dosing, and predicting adverse reactions. Integration with Qatar's national electronic health records creates a uniquely powerful research dataset combining genomic and clinical data.

Qatar's genomics investment positions it at the frontier of population health research for underserved populations. As precision medicine becomes the global standard of care, Qatar's database becomes a critical resource for any healthcare company wanting to serve Middle Eastern, North African, and South Asian populations — demographic groups representing billions of people whose genetic profiles are poorly understood by current medical science.